Dr. Danuta Cichocka
CEO, Co-Founder
Danuta is responsible for the company’s strategy development and implementation, general management and fundraising. Danuta is a microbiologist by training.
She completed her PhD at the UFZ Leipzig in 2008. In 2016 she completed the Executive MBA program at the EPFL and obtained a Certificate of Advanced Studies (CAS) in Management of Biotech, Medtech & Pharma Ventures.
In 2017 Danuta initiated the collaboration with EPFL-LPMV on the commercialization of nanoscale motion detection technology for phenotypic AST, which resulted in the establishment of Resistell AG in 2018. In the little free time left, Danuta enjoys photography, skiing and mountain biking.
